James Crowley: Fibrosis Can Be Caused by Mechanical Disruption of the Lymphatic Vessels Alone
James Crowley, Professor of Medicine Emeritus at Brown University, Captain at U.S. Navy Reserve, shared a post on LinkedIn about a recent article by Hailey M. Shepherd et al, adding:
“Authors Kreisel and Shepherd from WashU emphasized that the research team conducted these transplants among genetically identical mice, whose tissues could not generate an immune response against one another.
This provides evidence that the fibrosis is independent of immunity against foreign tissues and instead can be caused by the mechanical disruption of the lymphatic vessels alone.
The treatment that blocked the protein responsible for manufacturing hyaluronan is called 4-methylumbelliferone (4-MU).
It is approved for use in Europe and Asia to treat biliary disorders, conditions that affect the gallbladder.
According to the researchers, it has an excellent safety profile and is therefore a promising potential route to evaluating this approach in transplant patients.”
Title: Lymphatic disruption drives lung transplant fibrosis through interleukin-1–mediated hyaluronan accumulation
Authors: Hailey M. Shepherd, Wenjun Li, Benjamin J. Kopecky, Yuriko Terada, Charles R. Liu, Zhiyi Liu, Daniel D. Lee, Katsutaka Mineura, Hao Dun, Yuhei Yokoyama, Brian W. Wong, Gokalp K. Kurtoglu, Junedh M. Amrute, Davide Scozzi, Yun Zhu Bai, Amit I. Bery, Cory T. Bernadt, Jon H. Ritter, Steven L. Brody, Derek E. Byers, Alexander S. Krupnick, Ruben G. Nava, G. Alexander Patterson, Varun Puri, Andrew E. Gelman, Kory J. Lavine, Gwendalyn J. Randolph, Daniel Kreisel
Read the Full Article on Science

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026
-
Jul 12, 2026, 06:59Maaike Sybil Jongen: Flow Cytometry for Platelet Phenotyping at ISTH 2026